MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy

Neurology
Whitney B PopeTimothy Cloughesy

Abstract

Patients with recurrent gliomas (n = 14) were treated with bevacizumab and carboplatin, cpt-11, or etoposide. Follow-up MRI scans were obtained 2 to 6 weeks after initiation of treatment. Contrast-enhancing tumor shrank in 7 patients, with reductions evident in as little as 2 weeks after initiation of therapy. Treatment seemed more effective for heterogeneously enhancing tumor compared with solidly enhancing tumor.

Citations

Jul 29, 2008·Journal of Neuro-oncology·Camilo E FadulJ Marc Pipas
Dec 2, 2008·Journal of Neuro-oncology·Andrew D NordenPatrick Y Wen
Mar 27, 2007·Pharmaceutical Research·Renu M Stephen, Robert J Gillies
Sep 8, 2010·Targeted Oncology·Priscilla K Brastianos, Tracy T Batchelor
Oct 13, 2006·Current Treatment Options in Oncology·Kamalakannan PalanichamyArnab Chakravarti
Feb 8, 2008·Current Treatment Options in Oncology·David A ReardonJames J Vredenburgh
Apr 22, 2009·Current Treatment Options in Oncology·Jimmy Ruiz, Glenn J Lesser
Apr 8, 2009·Current Neurology and Neuroscience Reports·Jennifer L Clarke, Susan Chang
Apr 8, 2009·Current Neurology and Neuroscience Reports·Elizabeth R GerstnerTracy T Batchelor
Mar 27, 2013·Current Neurology and Neuroscience Reports·Olivier L ChinotTimothy F Cloughesy
Apr 29, 2010·Current Oncology Reports·Mustafa Khasraw, Andrew B Lassman
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew S ChiPatrick Y Wen
Feb 21, 2008·Nature Clinical Practice. Oncology·David Schiff, Benjamin Purow
Jun 11, 2008·Nature Clinical Practice. Oncology·Maciej M Mrugala, Marc C Chamberlain
Aug 20, 2008·Nature Clinical Practice. Oncology·A Gregory SorensenRakesh K Jain
Apr 1, 2009·Nature Reviews. Clinical Oncology·Elizabeth R GerstnerTracy T Batchelor
Oct 7, 2009·Nature Reviews. Clinical Oncology·Isaac Yang, Manish K Aghi
Oct 15, 2009·Nature Reviews. Neurology·Andrew D NordenPatrick Y Wen
Feb 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Olivier KeunenSimone P Niclou
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yasushi SodaInder M Verma
Jan 13, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J J C VerhoeffD J Richel
Jul 16, 2011·Neuro-oncology·Christian la FougèreJörg-Christian Tonn
Nov 9, 2012·Neuro-oncology·Michael WellerWolfgang Wick
Oct 9, 2008·Current Opinion in Oncology·Andrew D NordenPatrick Y Wen
Feb 1, 2012·The Cancer Journal·Elizabeth R Gerstner, Tracy T Batchelor
Mar 31, 2009·Cold Spring Harbor Symposia on Quantitative Biology·J N Rich, C E Eyler
Dec 10, 2009·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Meng Law
Nov 29, 2011·International Journal of Molecular Imaging·J Matthew Debnam, Dawid Schellingerhout
Dec 18, 2009·BMC Cancer·Joost J C VerhoeffWouter R van Furth
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dan G DudaChristopher G Willett
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walid S KamounRakesh K Jain
Jan 6, 2011·Neurology·Eric M ThompsonEdward A Neuwelt
Apr 26, 2008·Neuro-oncology·Phioanh Leia NghiemphuTimothy F Cloughesy
Aug 19, 2008·Neuro-oncology·Candelaria Gomez-ManzanoW K Alfred Yung
Jun 19, 2010·Neurosurgery·Eric M ThompsonEdward A Neuwelt
Feb 8, 2011·PloS One·Charles W KanalyJohn H Sampson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
James VredenburghHenry S Friedman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James VredenburghHenry S Friedman
The New England Journal of Medicine
Roger StuppNational Cancer Institute of Canada Clinical Trials Group
© 2022 Meta ULC. All rights reserved